IMO what the outcome of their investigation will be for so called “pumping” the stock.
“This drug seems to do everything they say it does!”
Time will tell. Bottom line the drug works and NASH will be the second step after HIV.
Patient volumes are up in Brazil so COVID will soon follow. I’m expecting an update on trial participants. I hope they hold off until the trial is filled or better yet, wait and just announce an EUA.
The relentlessly bashing is not scaring off any longs.
Published peer review from Italy just reinforces how great this drug is.
Cary on NP and Kelly good work! Let’s save some lives. That’s what it’s all about.
Those that fight to keep this drug from coming to market should be held accountable.
Too many catalysts occurring to try a discredit the drug and it’s potential.
BTD for mTNBC will be resubmitted and CYDY will show superior results to the current SOC. You can mark my words on that comment.